BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8603340)

  • 21. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
    Tahara H; Smith AP; Gaz RD; Arnold A
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer.
    Okamoto A; Hussain SP; Hagiwara K; Spillare EA; Rusin MR; Demetrick DJ; Serrano M; Hannon GJ; Shiseki M; Zariwala M
    Cancer Res; 1995 Apr; 55(7):1448-51. PubMed ID: 7882351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas.
    Gombart AF; Morosetti R; Miller CW; Said JW; Koeffler HP
    Blood; 1995 Aug; 86(4):1534-9. PubMed ID: 7632961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies.
    Shiohara M; Spirin K; Said JW; Gombart AF; Nakamaki T; Takeuchi S; Hatta Y; Morosetti R; Tasaka T; Seriu T; Bartram C; Miller CW; Tomonaga M; Koeffler HP
    Leukemia; 1996 Dec; 10(12):1897-900. PubMed ID: 8946928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma.
    Tasaka T; Berenson J; Vescio R; Hirama T; Miller CW; Nagai M; Takahara J; Koeffler HP
    Br J Haematol; 1997 Jan; 96(1):98-102. PubMed ID: 9012694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p16ink4a gene and hematological malignancies.
    Quesnel B; Preudhomme C; Fenaux P
    Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
    Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S
    Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
    Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
    Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma.
    Koduru PR; Zariwala M; Soni M; Gong JZ; Xiong Y; Broome JD
    Blood; 1995 Oct; 86(8):2900-5. PubMed ID: 7579381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p15ink4B and p16ink4 gene inactivation in acute lymphocytic leukemia.
    Rasool O; Heyman M; Brandter LB; Liu Y; Grandér D; Söderhäll S; Einhorn S
    Blood; 1995 Jun; 85(12):3431-6. PubMed ID: 7780130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.
    Lee YY; Kang SH; Seo JY; Jung CW; Lee KU; Choe KJ; Kim BK; Kim NK; Koeffler HP; Bang YJ
    Cancer; 1997 Nov; 80(10):1889-96. PubMed ID: 9366289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of the INK4 family of genes in prostate carcinomas.
    Park DJ; Wilczynski SP; Pham EY; Miller CW; Koeffler HP
    J Urol; 1997 May; 157(5):1995-9. PubMed ID: 9112579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance.
    Diccianni MB; Chau LS; Batova A; Vu TQ; Yu AL
    Cancer Lett; 1996 Jul; 104(2):183-92. PubMed ID: 8665486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.
    Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S
    Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.
    Zariwala M; Liu E; Xiong Y
    Oncogene; 1996 Jan; 12(2):451-5. PubMed ID: 8570224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas.
    Kawamata N; Seriu T; Koeffler HP; Bartram CR
    Cancer; 1996 Feb; 77(3):570-5. PubMed ID: 8630967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma.
    Siebert R; Willers CP; Opalka B
    Leuk Lymphoma; 1996 Nov; 23(5-6):505-20. PubMed ID: 9031081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies.
    Ogawa S; Hangaishi A; Miyawaki S; Hirosawa S; Miura Y; Takeyama K; Kamada N; Ohtake S; Uike N; Shimazaki C
    Blood; 1995 Aug; 86(4):1548-56. PubMed ID: 7632963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.